You are here

News story

Any general news stories or articles in the media we believe are of interest to you

CMLSg's comment on FAD: 1st line use of dasatinib, nilotinib, imatinib. CMLSg will not appeal this FAD.

sandy craine's picture
Submitted by sandy craine on Fri, 23/03/2012 - 10:24am
In the circumstances we feel we have done all we can and that an appeal is not a positive option for us.

In the circumstances we feel we have done all we can and that an appeal is not a positive option for us.

BBC News regarding NICE appraisal of dasatinib and nilotinib- plus TV3 interview regarding tasigna

sandy craine's picture
Submitted by sandy craine on Wed, 06/01/2010 - 11:40am
BBC News regarding NICE appraisal of dasatinib and nilotinib http://news.bbc.co.uk/1/hi/england/london/8440877.stm

BBC News regarding NICE appraisal of dasatinib and nilotinib
http://news.bbc.co.uk/1/hi/england/london/8440877.stm

And then there was Glivec

sandy craine's picture
Submitted by sandy craine on Tue, 19/09/2006 - 4:19pm
A race against time... Patients' clamour for Gleevec began in spring 1999, as soon as the results of the first tests on CML patients spread. Thanks to the Internet they were aware of the drug from its early stages.

A race against time... Patients' clamour for Gleevec began in spring 1999, as soon as the results of the first tests on CML patients spread. Thanks to the Internet they were aware of the drug from its early stages.

Pages